AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Woitge, HW Horn, E Keck, AV Auler, B Seibel, MJ Pecherstorfer, M
Citation: Hw. Woitge et al., Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis, CLIN CHEM, 47(4), 2001, pp. 686-693

Authors: Woitge, HW Pecherstorfer, M Horn, E Keck, AV Diel, IJ Bayer, P Ludwig, H Ziegler, R Seibel, MJ
Citation: Hw. Woitge et al., Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma, BR J CANC, 84(3), 2001, pp. 344-351

Authors: Pecherstorfer, M Jilch, R Sauty, A Horn, E Keck, AV Zimmer-Roth, I Thiebaud, D
Citation: M. Pecherstorfer et al., Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations, J BONE MIN, 15(1), 2000, pp. 147-154

Authors: Pecherstorfer, M Vesely, M
Citation: M. Pecherstorfer et M. Vesely, Diagnosis and monitoring of bone metastases: Clinical means, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 97-129

Authors: Diel, IJ Solomayer, EF Seibel, MJ Pfeilschifter, J Maisenbacher, H Gollan, C Pecherstorfer, M Conradi, R Kehr, G Boehm, E Armbruster, FP Bastert, G
Citation: Ij. Diel et al., Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis, CLIN CANC R, 5(12), 1999, pp. 3914-3919

Authors: Hausmaninger, H Moser, R Samonigg, H Mlineritsch, B Schmidt, H Pecherstorfer, M Fridrik, M Kopf, C Nitsche, D Kaider, A Ludwig, H
Citation: H. Hausmaninger et al., Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: Final resultsof a randomised phase III study, EUR J CANC, 35(3), 1999, pp. 380-385

Authors: Woitge, HW Pecherstorfer, M Li, YM Keck, AV Horn, E Ziegler, R Seibel, MJ
Citation: Hw. Woitge et al., Novel serum markers of bone resorption: Clinical assessment and comparisonwith established urinary indices, J BONE MIN, 14(5), 1999, pp. 792-801

Authors: Zojer, N Keck, AV Pecherstorfer, M
Citation: N. Zojer et al., Comparative tolerability of drug therapies for hypercalcaemia of malignancy, DRUG SAFETY, 21(5), 1999, pp. 389-406

Authors: Rizzoli, R Thiebaud, D Bundred, N Pecherstorfer, M Herrmann, Z Huss, HJ Ruckert, F Manegold, C Tubiana-Hulin, M Steinhauer, EU Degardin, M Thurlimann, B Clemens, MR Eghbali, H Body, JJ
Citation: R. Rizzoli et al., Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy, J CLIN END, 84(10), 1999, pp. 3545-3550
Risultati: 1-9 |